Alaunos Therapeutics (TCRT) Revenue & Revenue Breakdown
Alaunos Therapeutics Revenue Highlights
Latest Revenue (Y)
$5.00K
Latest Revenue (Q)
$4.00K
Alaunos Therapeutics Revenue by Period
Alaunos Therapeutics Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | -99.83% |
2022-12-31 | - | 634.17% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | -100.00% |
2018-12-31 | - | -97.71% |
2017-12-31 | - | -6.88% |
2016-12-31 | - | 58.38% |
2015-12-31 | - | 215.51% |
2014-12-31 | - | 71.63% |
2013-12-31 | - | - |
2012-12-31 | - | 19.94% |
2011-12-31 | - | 100.00% |
2010-12-31 | - | 100.00% |
2009-12-31 | - | 100.00% |
2008-12-31 | - | 100.00% |
2007-12-31 | - | 100.00% |
2006-12-31 | - | 100.00% |
2005-12-31 | - | 100.00% |
2004-12-31 | - | 100.00% |
2003-12-31 | - | -100.00% |
2002-12-31 | - | 48.90% |
2001-12-31 | - | - |
Alaunos Therapeutics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 300.00% |
2024-03-31 | - | - |
2023-12-31 | - | 100.00% |
2023-09-30 | - | -100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | -100.00% |
2022-12-31 | - | -99.62% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | -100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | -100.00% |
2018-03-31 | - | -90.86% |
2017-12-31 | - | -0.06% |
2017-09-30 | - | 0.06% |
2017-06-30 | - | - |
2017-03-31 | - | - |
2016-12-31 | - | -0.06% |
2016-09-30 | - | -5.83% |
2016-06-30 | - | -13.81% |
2016-03-31 | - | 2.61% |
2015-12-31 | - | 2.68% |
2015-09-30 | - | 587.13% |
2015-06-30 | - | - |
2015-03-31 | - | -20.00% |
2014-12-31 | - | -46.29% |
2014-09-30 | - | 216.50% |
2014-06-30 | - | - |
2014-03-31 | - | - |
2013-12-31 | - | - |
2013-09-30 | - | - |
2013-06-30 | - | - |
2013-03-31 | - | - |
2012-12-31 | - | - |
2012-09-30 | - | - |
2012-06-30 | - | - |
2012-03-31 | - | - |
2011-12-31 | - | - |
2011-09-30 | - | - |
2011-06-30 | - | 198.51% |
2011-03-31 | - | 100.00% |
2010-12-31 | - | 100.00% |
2010-09-30 | - | 100.00% |
2010-06-30 | - | 100.00% |
2010-03-31 | - | 100.00% |
2009-12-31 | - | 100.00% |
2009-09-30 | - | 100.00% |
2009-06-30 | - | 100.00% |
2009-03-31 | - | 100.00% |
2008-12-31 | - | 100.00% |
2008-09-30 | - | 100.00% |
2008-06-30 | - | 100.00% |
2008-03-31 | - | 100.00% |
2007-12-31 | - | - |
Alaunos Therapeutics Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
RIGL | Rigel Pharmaceuticals | - | - |
ADAP | Adaptimmune Therapeutics | - | - |
PIRS | Pieris Pharmaceuticals | - | - |
MRSN | Mersana Therapeutics | - | - |
FENC | Fennec Pharmaceuticals | - | - |
STOK | Stoke Therapeutics | - | - |
CUE | Cue Biopharma | - | - |
VRCA | Verrica Pharmaceuticals | - | - |
FIXX | Q32 Bio | - | - |
CKPT | Checkpoint Therapeutics | - | - |
TCRT | Alaunos Therapeutics | - | - |
LIAN | LianBio | - | - |
BDTX | Black Diamond Therapeutics | - | - |
INKT | MiNK Therapeutics | - | - |
MDNA | Medicenna Therapeutics | - | - |
ACHL | Achilles Therapeutics | - | - |
LRMR | Larimar Therapeutics | - | - |